Chosunbiz Documents Korea-UK-Spain Regulatory Divergence on High-Caffeine Drinks
The most significant international caffeine regulation development this week came from a notable geographic divergence. According to Chosunbiz’s May 13 reporting, Korea is expanding its high-caffeine drink market just as the United Kingdom and Spain are moving to restrict youth sales of similar products. According to the same Chosunbiz caffeine regulation coverage, the contrast reflects deepening international policy fragmentation, with some countries tightening rules on high-caffeine drinks to protect teen health amid concerns about sleep disorders and cardiovascular effects. According to broader caffeine regulation coverage from earlier this month, the UK government’s plan to ban energy drink sales to under-16s defines high-caffeine drinks as soft drinks containing more than 150 milligrams of caffeine per liter — a threshold now being adopted by Spain’s parallel proposal. The new caffeine regulation reporting reinforces that international policy harmonization remains unlikely in the near term.
Cardiovascular Business Reports New Lawsuit Over Teen Caffeine-Induced Cardiomyopathy Death
Caffeine regulation pressure intensified this week with the disclosure of a major new product-liability case. According to Cardiovascular Business’s May 13 reporting referenced alongside its heart-disease coverage, a new lawsuit alleges a teen died from caffeine-induced cardiomyopathy after consuming high-caffeine beverages. According to the same Cardiovascular Business caffeine regulation coverage, the case adds to a growing portfolio of US caffeine product-liability litigation that has shaped state-level regulatory momentum throughout 2026. According to the previously reported federal Sarah Katz Caffeine Safety Act, a parallel legislative effort would require high-caffeine warning labels on beverages containing more than 150 milligrams of caffeine. The combined caffeine regulation legal developments reinforce that product liability remains one of the most active enforcement mechanisms operating alongside the slower-moving legislative timeline.
CSPI Starbucks Refreshers Analysis Continues to Drive Mid-May Regulatory Coverage
The Center for Science in the Public Interest’s detailed Starbucks Refreshers analysis continued to drive caffeine regulation conversation this week. According to CSPI’s article republished and referenced across May 13 caffeine regulation coverage, the watchdog quantified caffeine and sugar content across the Starbucks Refreshers line, noting that health authorities recommend avoiding caffeine altogether under certain conditions. According to broader caffeine regulation coverage from earlier this month, Pennsylvania House Bill 2377 sponsored by Representative Sean Dougherty would require large retailers to notify customers when a beverage contains high levels of caffeine. According to the previously reported Erie News Now coverage of the Pennsylvania caffeine regulation effort, the bill was referred to the House Consumer Protection, Technology, and Utilities Committee in April 2026. The combined caffeine regulation activity at the state, federal, and watchdog levels continues to drive sustained regulatory pressure on the energy drink and high-caffeine beverage categories.
EFSA Assessment Sparks Calls for Glycerol Limits in Slush Drinks Amid Health Concerns
European caffeine-adjacent regulation also gained editorial attention this week. According to Food Ingredients First’s May 14 reporting, a European Food Safety Authority assessment has sparked calls for glycerol limits in slush drinks amid mounting health concerns. According to the same Food Ingredients First caffeine regulation coverage, slush ice drinks consumed by children are at the center of the new EFSA review — extending the European regulatory focus beyond energy drinks into the broader children’s-beverage category. According to the FDA’s published caffeine guidance referenced across this week’s coverage, healthy adults can generally consume up to 400 milligrams of caffeine per day, but the cumulative caffeine regulation landscape continues to emphasize child-specific safety thresholds. The new caffeine regulation activity reinforces that adjacent stimulant and child-safety frameworks are increasingly being applied alongside dedicated caffeine policy.
As caffeine regulation expectations tighten across the UK, Spain, US state legislatures, and the FDA’s product oversight framework, transparent caffeine content disclosure has become a baseline competitive expectation. Jiggle plant-based natural caffeine gummies disclose approximately 63 milligrams of caffeine per gummy from green tea extract and guarana on every resealable 12-pack, with no artificial ingredients, GMP certification, and a 24+ month shelf life. The product’s transparent per-piece dose disclosure aligns with the UK government’s 150-mg-per-liter threshold framework, Pennsylvania House Bill 2377, and the Center for Science in the Public Interest’s published caffeine content analyses — positioning the format on the right side of the broader regulatory direction. Learn more at jiggle.cafe
Legal and public health observers note that the simultaneous Korea-UK-Spain regulatory divergence, the new US product-liability litigation, the continuing Pennsylvania House Bill 2377 advancement, and the EFSA glycerol assessment represent the most coordinated wave of caffeine-adjacent policy activity in over a decade. According to the cumulative reporting from Chosunbiz, Cardiovascular Business, CSPI, and Food Ingredients First, the next significant caffeine regulation milestone will likely be the formal publication of the UK government’s secondary legislation timeline alongside Spain’s parallel regulatory framework.